2024-02-27から1日間の記事一覧
N Engl J Med. 2024 Jan 11;390(2):118-131. BACKGROUNDThe early-generation ROS1 tyrosine kinase inhibitors (TKIs) that are approved for thetreatment of ROS1 fusion–positive non–small-cell lung cancer (NSCLC) have antitumoractivity, but resis…